Global Percutaneous Transluminal Angioplasty (PTA) Balloons Market: By Product Type (Drug Eluting Balloons, Normal Balloons, Scoring Balloons, Cutting Balloons), By Application (Peripheral Artery Disease, Coronary Artery Disease), By End Users (Hospitals, Clinics, Ambulatory Surgical Centers), and Geography 


Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Percutaneous Transluminal Angioplasty (PTA) Balloons Market is expected to grow at a CAGR of 4% during the forecast peirod 2022 to 2028. Percutaneous transluminal angioplasty (PTA) is a process carried to treat the peripheral artery disease (PAD) by open up the arteries that are narrowed by plaque. Percutaneous transluminal angioplasty (PTA) is a procedure in which a small flexible catheter with a diameter of only a few millimetres is introduced into an artery and guided to a desired site where the blood vessel has narrowed due to cardiovascular disease. A tiny balloon is inflated at the end of the catheter when it reaches the target place, squeezing the blocking component responsible for the restricted artery against the blood vessel wall and restoring normal blood flow. When the balloon is inflated, the blood vessel opening widens, allowing more blood to flow to the heart. During the procedure, a stent is frequently used to maintain the artery open after the balloon is deflated and removed. Superior technological advancements such as progressive flexibility due to innovations in hydrophilic design, superior hydrophilic coatings, improved performance under high pressure due to added pushability, and robust design reducing friction are expected to drive the global percutaneous transluminal angioplasty balloons market growth during the forecast period. Rising reimbursement coverage for the treatment of cardiac diseases, especially among end-users in developing countries (which have a relatively higher patient population), are some of the factors likely to drive the growth of the global percutaneous transluminal angioplasty balloons market between 2017 and 2025. However, the risk of patient discomfort during balloon inflation and the possibility of restenosis are two factors that are anticipated to limit the worldwide Percutaneous Transluminal Angioplasty (PTA) Balloons Market growth over the forecast period.

Percutaneous Transluminal Angioplasty Pta Balloons Market Summary

Study Period


Base Year




Largest Market

North America

Fastest Growing Market


Increase in the prevalence of peripheral or coronary artery diseases, development in imaging technologies, recent launch of several percutaneous transluminal angioplasty balloons, and rise in R&D for the manufacturing of advanced technology balloons such as drug-eluting balloons are anticipated to fuel the percutanleous transluminal angioplasty balloons market over the forecast period. However, stringent guidelines for product approval, high cost of PTA balloons, and lack of awareness about advanced PTA balloons in underdeveloped countries may restrain the growth of percutaneous transluminal angioplasty balloons market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Percutaneous Transluminal Angioplasty Pta Balloons Market Segmentation

Product Type
  • Drug-Eluting Balloons
  • Normal Balloons
  • Scoring Balloons
  • Cutting Balloons
  • Peripheral Artery Disease
  • Coronary Artery Disease
End User
  • Hospitals
  • Cardiology Clinics
  • Ambulatory Surgical Centers


Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

[urltag url='request-table-of-content']

  • R. Bard, Inc. (U.S.)
  • Cook Medical, Inc. (U.S.)
  • Abbott, Inc. (U.S.)
  • Cardinal Health, Inc. (U.S.)
  • Boston Scientific Corporation (U.S.)
  • Spectranetics Corporation (Philips Holding USA Inc.) (U.S.)
  • Medtronic Plc (Ireland)
  • SurModics Inc. (U.S.)
  • ENDOCOR GmbH (Germany)